IceCure Medical Ltd. Files December 2025 6-K Report
Ticker: ICCM · Form: 6-K · Filed: Dec 3, 2025 · CIK: 1584371
Sentiment: neutral
Topics: 6-K, meeting-notice, proxy-statement
Related Tickers: ICCM
TL;DR
ICCM files 6-K with meeting notice & proxy for Dec 2025.
AI Summary
IceCure Medical Ltd. filed a Form 6-K on December 3, 2025, reporting for the month of December 2025. The filing includes a Notice of Meeting and Proxy Statement. The company is incorporated in Israel and its principal executive offices are located in Caesarea.
Why It Matters
This filing provides shareholders with important information regarding upcoming meetings and voting procedures, impacting their ability to influence company decisions.
Risk Assessment
Risk Level: low — This is a routine filing providing notice of a meeting and proxy information, not indicating any immediate financial or operational risks.
Key Players & Entities
- IceCure Medical Ltd. (company) — Registrant
- 001-40753 (company) — Commission File Number
- 7 Ha'Eshel St., PO Box 3163 Caesarea, 3079504 Israel (company) — Principal executive offices address
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K filing is a Report of Foreign Private Issuer for the month of December 2025, and it incorporates by reference a Notice of Meeting and Proxy Statement.
When was this report filed with the SEC?
This report was filed as of December 3, 2025.
What is the company's primary business address?
The company's principal executive offices are located at 7 Ha'Eshel St., PO Box 3163, Caesarea, 3079504, Israel.
Does IceCure Medical Ltd. file annual reports under Form 20-F or 40-F?
IceCure Medical Ltd. files annual reports under Form 20-F, as indicated by the checkmark next to it.
What is the Commission File Number for IceCure Medical Ltd.?
The Commission File Number for IceCure Medical Ltd. is 001-40753.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on December 3, 2025 regarding IceCure Medical Ltd. (ICCM).